Molecular Characterization of Acquired Resistance To Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients

被引:0
|
作者
Bellosillo, Beatriz [1 ]
Dahnases, Alba [1 ]
Martinez, Alejandro [1 ]
Iglesias, Mar [1 ]
Gonzalez, Irio [1 ]
Salido, Marta [1 ]
Busto, Marcos [1 ]
Sanchez, Juan [1 ]
Vidal, Joana [1 ]
Clave, Sergi [1 ]
Moragon, Ester [1 ]
Pairet, Silvia [1 ]
Bellmunt, Joaquim [1 ]
Serrano, Sergio [1 ]
Rovira, Ana [1 ]
Albanell, Joan [1 ]
Montagut, Clara [1 ]
机构
[1] Hosp del Mar, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
583
引用
收藏
页码:148A / 148A
页数:1
相关论文
共 50 条
  • [11] Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies
    Zhang, Wu
    Gordon, Michael
    Lenz, Heinz-Josef
    ANNALS OF MEDICINE, 2006, 38 (08) : 545 - 551
  • [12] Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    Sandra Misale
    Rona Yaeger
    Sebastijan Hobor
    Elisa Scala
    Manickam Janakiraman
    David Liska
    Emanuele Valtorta
    Roberta Schiavo
    Michela Buscarino
    Giulia Siravegna
    Katia Bencardino
    Andrea Cercek
    Chin-Tung Chen
    Silvio Veronese
    Carlo Zanon
    Andrea Sartore-Bianchi
    Marcello Gambacorta
    Margherita Gallicchio
    Efsevia Vakiani
    Valentina Boscaro
    Enzo Medico
    Martin Weiser
    Salvatore Siena
    Federica Di Nicolantonio
    David Solit
    Alberto Bardelli
    Nature, 2012, 486 : 532 - 536
  • [13] Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Zacharenia Saridaki
    Vassilis Georgoulias
    John Souglakos
    World Journal of Gastroenterology, 2010, 16 (10) : 1177 - 1187
  • [14] Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    Misale, Sandra
    Yaeger, Rona
    Hobor, Sebastijan
    Scala, Elisa
    Janakiraman, Manickam
    Liska, David
    Valtorta, Emanuele
    Schiavo, Roberta
    Buscarino, Michela
    Siravegna, Giulia
    Bencardino, Katia
    Cercek, Andrea
    Chen, Chin-Tung
    Veronese, Silvio
    Zanon, Carlo
    Sartore-Bianchi, Andrea
    Gambacorta, Marcello
    Gallicchio, Margherita
    Vakiani, Efsevia
    Boscaro, Valentina
    Medico, Enzo
    Weiser, Martin
    Siena, Salvatore
    Di Nicolantonio, Federica
    Solit, David
    Bardelli, Alberto
    NATURE, 2012, 486 (7404) : 532 - U131
  • [15] Anti-EGFR monoclonal antibodies in lung cancer treatment
    Schiller, Joan H.
    LANCET ONCOLOGY, 2015, 16 (07): : 738 - 739
  • [16] Anti-EGFR monoclonal antibody treatment in colorectal cancer
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (6): : 249 - 250
  • [17] Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Saridaki, Zacharenia
    Georgoulias, Vassilis
    Souglakos, John
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (10) : 1177 - 1187
  • [18] Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
    F Di Fiore
    R Sesboüé
    P Michel
    J C Sabourin
    T Frebourg
    British Journal of Cancer, 2010, 103 : 1765 - 1772
  • [19] Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
    Di Fiore, F.
    Sesbouee, R.
    Michel, P.
    Sabourin, J. C.
    Frebourg, T.
    BRITISH JOURNAL OF CANCER, 2010, 103 (12) : 1765 - 1772
  • [20] Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis
    van Helden, E. J.
    van Oordt, C. W. Menke-van der Houven
    Heymans, M. W.
    Ket, J. C. F.
    van den Oord, R.
    Verheul, H. M. W.
    CANCER AND METASTASIS REVIEWS, 2017, 36 (02) : 395 - 406